3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Menactra: new trials by email Literature Review of Menactra trials Research Report on Menactra
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali Pfs25M-EPA, Pfs230D1M-EPA, AS01 - Malaria | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 301 | 2016-10-21 | 2024-12-10 |
| Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali Pfs230D1M-EPA/Alhydrogel, Pfs25M-EPA/Alhydrogel, TWINRIX - Malaria | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 538 | 2015-01-07 | 2019-04-11 |
| Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine Pfs25-EPA/Alhydrogel, Euvax B, Menactra - Malaria | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 230 | 2013-03-27 | 2018-07-05 |
Malaria (3)
National Institute of Allergy and Infectious Diseases (NIAID) (3)
Mali (3) · United States (1)
Patrick E Duffy, M.D. (2) · Sara A Healy, M.D. (1)
PMID 39787798, PMID 30061051, PMID 31307393, PMID 33561016, PMID 37027391, PMID 37499679, PMID 40552966